Search results
- 452.91Add to watchlist-1.51 (-0.33%)As of Thu. May 30, 2024 9:43 AM EDT · Nasdaq Real Time Price (USD) · Market open
- Open454.84High455.86Low452.16
- Mkt Cap146.05BP/E (TTM)17.66Div & Yield11.00 & 2.41%
- Prev. Close454.4252 Wk. Low289.3652 Wk. High471.48
What analysts are sayingRelated stocks
13 hours ago · GSK. -. On Thursday, Goldman Sachs initiated coverage on GlaxoSmithKline (NYSE: GSK :LN) (NYSE: GSK), issuing a Neutral rating with a price target of £18.50 for the pharmaceutical company. The ...
13 hours ago · 2024-05-30 09:19. On Thursday, Goldman Sachs (NYSE: GS ) initiated coverage on GlaxoSmithKline (NYSE: GSK :LN) (NYSE: GSK), issuing a Neutral rating with a price target of £18.50 for the pharmaceutical company. The firm highlighted GlaxoSmithKline's transition from a conglomerate to a company focused on specialty medicines and vaccines, which ...
13 hours ago · Goldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a neutral. ... Zantac litigation will remain an overhang on the stock, they added, with about ...
13 hours ago · Published 05/30/2024, 05:19 AM. 0. NVO. -1.04%. On Thursday, Goldman Sachs initiated coverage on Novo Nordisk (NOVOB:DC) (NYSE: NYSE: NVO) stock with a Buy rating and a price target of DKK1,075.00 ...
13 hours ago · On Thursday, Goldman Sachs initiated coverage of Baxter International (NYSE:BAX), assigning a Neutral rating to the healthcare company's shares with a price target of $36.00. The firm's analysis suggests that Baxter's operating performance is expected to improve in the coming months, with an ...
